参考文献

2020-10-21

1: Ciacciarelli M, Zerbinati C, Violi F, Iuliano L. Dipyridamole: a drug with unrecognized antioxidant activity. Curr Top Med Chem. 2015;15(9):822-9. Review. PubMed PMID: 25697566.

2: Balakumar P, Nyo YH, Renushia R, Raaginey D, Oh AN, Varatharajan R, Dhanaraj SA. Classical and pleiotropic actions of dipyridamole: Not enough light to illuminate the dark tunnel? Pharmacol Res. 2014 Sep;87:144-50. doi: 10.1016/j.phrs.2014.05.008. Epub 2014 May 24. Review. PubMed PMID: 24861566.

3: Cullis PS, Watson D, Cameron A, McKee RF. Dipyridamole and paracetamol overdose resulting in multi-organ failure. Scott Med J. 2013 Aug;58(3):e14-7. doi: 10.1177/0036933013496926. Review. PubMed PMID: 23960064.

4: Dewilde S, Hawkins N. Investigating incoherence gives insight: clopidogrel is equivalent to extended-release dipyridamole plus aspirin in secondary stroke prevention. J Clin Epidemiol. 2012 Aug;65(8):835-45. doi: 10.1016/j.jclinepi.2012.01.019. Review. PubMed PMID: 22726765.

5: Eisert WG. Dipyridamole in antithrombotic treatment. Adv Cardiol. 2012;47:78-86. doi: 10.1159/000338053. Epub 2012 Aug 9. Review. PubMed PMID: 22906904.

6: Greenhalgh J, Bagust A, Boland A, Martin Saborido C, Oyee J, Blundell M, Dundar Y, Dickson R, Proudlove C, Fisher M. Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis. Health Technol Assess. 2011 Sep;15(31):1-178. doi: 10.3310/hta15310. Review. PubMed PMID: 21888837.

7: Melani A, Cipriani S, Corti F, Pedata F. Effect of intravenous administration of dipyridamole in a rat model of chronic cerebral ischemia. Ann N Y Acad Sci. 2010 Oct;1207:89-96. doi: 10.1111/j.1749-6632.2010.05732.x. Review. PubMed PMID: 20955431.

8: Pattillo CB, Fang K, Terracciano J, Kevil CG. Reperfusion of chronic tissue ischemia: nitrite and dipyridamole regulation of innate immune responses. Ann N Y Acad Sci. 2010 Oct;1207:83-8. doi: 10.1111/j.1749-6632.2010.05737.x. Review. PubMed PMID: 20955430; PubMed Central PMCID: PMC4414240.

9: d'Esterre CD, Lee TY. Effect of dipyridamole during acute stroke: exploring antithrombosis and neuroprotective benefits. Ann N Y Acad Sci. 2010 Oct;1207:71-5. doi: 10.1111/j.1749-6632.2010.05801.x. Review. PubMed PMID: 20955428.

10: Crown N, Mysak T. Safety of fixed-dose aspirin-extended-release dipyridamole in patients with ischemic heart disease. Am J Health Syst Pharm. 2010 May 1;67(9):728-33. doi: 10.2146/ajhp080645. Review. PubMed PMID: 20410547.

11: Bhavsar J, Rosenson RS. Adenosine transport, erythrocyte deformability and microvascular dysfunction: an unrecognized potential role for dipyridamole therapy. Clin Hemorheol Microcirc. 2010;44(3):193-205. doi: 10.3233/CH-2010-1274. Review. PubMed PMID: 20364065.

12: Salcedo J, Kern MJ. Effects of caffeine and theophylline on coronary hyperemia induced by adenosine or dipyridamole. Catheter Cardiovasc Interv. 2009 Oct 1;74(4):598-605. doi: 10.1002/ccd.22030. Review. PubMed PMID: 19496111.

13: Rouhl RP, Lodder J. ESPRIT: is aspirin plus dipyridamole superior to aspirin alone in TIA or minor stroke patients? Expert Rev Neurother. 2008 Nov;8(11):1661-5. doi: 10.1586/14737175.8.11.1661. Review. PubMed PMID: 18986236.

14: Chaturvedi S. Acetylsalicylic acid + extended-release dipyridamole combination therapy for secondary stroke prevention. Clin Ther. 2008 Jul;30(7):1196-205. Review. PubMed PMID: 18691981.

15: Kim HH, Liao JK. Translational therapeutics of dipyridamole. Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):s39-42. doi: 10.1161/ATVBAHA.107.160226. Epub 2008 Jan 3. Review. PubMed PMID: 18174451; PubMed Central PMCID: PMC2615560.

16: Halkes PH, Algra A. Anticoagulants, aspirin and dipyridamole in the secondary prevention of cerebral ischaemia: which is the best for which patient? Cerebrovasc Dis. 2007;24 Suppl 1:107-11. Epub 2007 Nov 1. Review. PubMed PMID: 17971645.

17: De Schryver EL, Algra A, van Gijn J. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease. Cochrane Database Syst Rev. 2007 Jul 18;(3):CD001820. Review. PubMed PMID: 17636684.

18: Weyrich AS, Kraiss LW, Prescott SM, Zimmerman GA. New roles for an old drug: inhibition of gene expression by dipyridamole in platelet-leukocyte aggregates. Trends Cardiovasc Med. 2006 Apr;16(3):75-80. Review. PubMed PMID: 16546687.

19: Sudlow C. What is the role of dipyridamole in long-term secondary prevention after an ischemic stroke or transient ischemic attack? CMAJ. 2005 Oct 25;173(9):1024-6. Review. PubMed PMID: 16247094; PubMed Central PMCID: PMC1266320.

20: De Schryver EL, Algra A, van Gijn J. Cochrane review: dipyridamole for preventing major vascular events in patients with vascular disease. Stroke. 2003 Aug;34(8):2072-80. Epub 2003 Jul 10. Review. PubMed PMID: 12855826.